Atlas Trials

Chronic Hepatitis C Virus Infection

19 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Chronic Hepatitis C Virus Infection

RecordFirmDate
Sofosbuvir/Ombitasvir/Paritaprevir/ Ritonavir and Ribavirin for Hepatitis C Virus Genotype 4 Patients (NCT04391985)Beni-Suef University2017-03-01
Sofosbuvir Plus Daclatasvir With or Without Ribavirin and Chronic HCV Genotype (GT) 4 (NCT04387526)Beni-Suef University2016-04-01
Ropeginterferon Alfa-2b (P1101) Phase 3 Study in Interferon Treatment-Naive Subjects With HCV Genotype 2 Infection (NCT04382937)PharmaEssentia2016-01-12
Sofosbuvir With Ribavirin or Simeprevir With HCV GT4 Egyptian Patients (NCT04385407)Beni-Suef University2015-04-01
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection (NCT02292719)AbbVie2014-12-19
Prospective Cohort Study: To Provide Evidence & Guidance in Hepatitis C Virus Screening, Comparing the New Birth Cohort Recommendations From the CDC, Versus Classical Traditional Strategies With Established Risk Factors (NCT01813266)Intermountain Health Care, Inc.2013-05-01
Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction (NCT01708889)Bristol-Myers Squibb2012-09-01
Hepatitis C in Renal Transplant Recipients (NCT02108301)Prof. Dr. Alice Schmidt2011-12-01
A Safety and Efficacy Study of the Combination of VX-222 and Telaprevir in Treatment-Naïve Subjects With Genotype 1 Chronic Hepatitis C Virus Infection (NCT01080222)Vertex Pharmaceuticals Incorporated2010-08-01
A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C (NCT01121731)Digna Biotech S.L.2010-05-01
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Multiple Doses of ABT-333 Alone and in Combination With Pegylated Interferon (pegIFN) and Ribavirin (RBV) in Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection (NCT00851890)AbbVie (prior sponsor, Abbott)2009-03-01
FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral Therapy (NCT00606528)University Health Network, Toronto2008-02-01
Study of CTS-1027 in Hepatitis C Patients (NCT00570336)Conatus Pharmaceuticals Inc.2007-12-01
Phase I/IIa Dose Ranging CHRONVAC-C® Study in Chronic HCV Patients (NCT00563173)Tripep AB2007-10-01
Safety, Tolerability and Efficacy of XTL 2125 in HCV-Infected Patients Who Are Interferon-Alpha Non-Responders or Relapsers (NCT00255359)Hadassah Medical Organization2006-02-01
Methacetin Breath Test in HCV Patients With Normal and Near-Normal ALT (NCT00294489)Hadassah Medical Organization2006-02-01
sgp130 in Chronic Human Liver Disease (NCT00770198)Erasme University Hospital2005-01-01
PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy (NCT00215865)Hepatitis Resource Network

Track Chronic Hepatitis C Virus Infection automatically

Every clearance here is in the API, with alerts when new ones post.